ArticleANZ journal of surgery2026
When Enzymes Mislead: Assessing the Value of MRCP in Suspected Choledocholithiasis.
Article in ANZ journal of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe diagnosis of choledocholithiasis (CDL) requires balancing timely intervention against the risks of unnecessary invasive procedures. Although liver function tests (LFTs) are widely used for risk stratification, their static values and short-term trends remain poorly defined in predicting persistent common bile duct stones. This study evaluated the association between static and dynamic LFTs and CDL and assessed the diagnostic performance of magnetic resonance cholangiopancreatography (MRCP).
methodsA retrospective review was conducted at Middlemore Hospital involving 504 acute inpatient MRCP scans within 2022. The collected clinical variables included patient demographics, LFTs and imaging modalities. 2 × 2 tables were constructed for those who had both MRCP and ERCP to assess the diagnostic utility of MRCP. Logistic regression and linear mixed-effects models were used to analyse the association between LFTs and CDL. Receiver operating characteristic curve analysis was performed to assess the diagnostic performance of each LFT.
resultsOf 504 MRCPs, 131 (26%) were positive for stones. Bilirubin, alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) were significantly higher in the CDL group on admission and repeat testing. Paradoxically, CDL was associated with a downward 24-h trend in ALP and GGT. Elevated GGT demonstrated the strongest independent association with CDL (adjusted OR: 5.27, 95% CI: 2.46-13.21; p < 0.001). Discriminatory performance of individual enzymes was modest (AUC: ALP 0.69; GGT 0.68; bilirubin 0.63). Among 157 patients undergoing both MRCP and ERCP, MRCP demonstrated high sensitivity (91.4%) but low specificity (32.7%).
conclusionStatic and dynamic LFTs provide limited discrimination for persistent CDL and improving biochemical trends do not reliably exclude stones. This study underscores the diagnostic utility of MRCP to prevent both missed CDL and avoidable ERCP, and the need for standardised diagnostic protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.